Transonic’s 354C Optima Flowmeter Simplifies Graft Patency Assessment for Surgical Decision-Making
ITHACA, N.Y. (PRWEB) November 14, 2017 -- Early graft failure after Coronary Artery Bypass Grafting (CABG) is reported in up to 12 percent of grafts. Three percent are clinically apparent and may contribute to early mortality. Graft failure can be due to vessel defects, anastomotic technical errors, poor native run-off or competitive flow. Repeat revascularization, if required, is expensive and puts patients at risk
To help cardiac surgeons identify and correct suspect grafts intraoperatively, Transonic introduces the Optima 354C Flowmeter, with automated Graft Patency Assessment. The Optima 354C assesses graft flow, flow waveforms and pressure signals and distills these into simple graft patency feedback for the surgeon. Transonic’s proven “Flow-based Intraoperative Coronary Artery Bypass Patency Assurance” protocols are the basis for the assessment.
As the creator of transit-time ultrasound volume flow measurement, Transonic has spent decades developing expertise in flow measurement and waveform morphology and advancing flow assessment algorithms.
“Surgeons cannot be expected to be waveform morphology experts,” said Miriam Tenorio, vice president of marketing at Transonic. “The Optima 354C will do that for them and provide an easy-to-use printout with mean flow, flow profile, pressure and an assessment of graft flow patency.”
“After hours spent recreating flow with complex grafts, confirming an adequate flow rate is a valuable final step in any CABG procedure,” said Tenorio. “The Optima 354C provides an easy-to-use, objective assessment of graft patency prior to closure to help avoid preventable reoperations.”
For more information about Transonic, visit its website or blog.
Media contact:
Miriam Tenorio
607-257-5300
Miriam Tenorio, Transonic Systems Inc., http://www.transonic.com, +1 (607) 257-5300 Ext: 327, [email protected]
Share this article